What Is Happening In Financial Markets Today?
"U.S.
Akari Therapeutics Plc (AKTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 179,785 | $210,330 | 0.38% | |
| 2. | Palo Alto Investors William Leland Edwards | 146,024 | $170,834 | 0.04% | |
| 3. | Renaissance Technologies Jim Simons | 17,415 | $20,374 | -6% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 3,000 | $2,700.00 | 298,574 | 2025-08-25 | Filing | |
| $0.93 | 8,000 | $7,440.00 | 295,574 | 2025-08-22 | Filing | |
| $0.94 | 10,000 | $9,400.00 | 287,574 | 2025-08-21 | Filing | |
| $1.16 | 5,203 | $6,035.48 | 277,574 | 2025-06-24 | Filing | |
| $1.15 | 943 | $1,084.45 | 272,371 | 2025-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 79,236 | $92,698 | 0% | |
| 2. | 62,690 | $73,341 | 0.03% | |
| 3. | 23,643 | $27,660 | 0% | |
| 4. | 18,408 | $21,536 | 0% | |
| 5. | 10,000 | $11,699 | 0.01% |
News See All
Here's What Is Happening In Financial Markets Today?
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
What Is Going On In The Financial Markets Today?
“U.S. stocks were slightly lower on Friday, dragged down by technology stocks as investors locked in gains of what is likely to be Wall Street's strongest first-quarter performance in four years.
What Do Hedge Funds Think of Akari Therapeutics PLC (ADR) (AKTX)?
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter.
Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited
In a recent filing with the Securities and Exchange Commission (SEC), James E.